June 1966

Streptomyces Products Inhibiting Mycobacteria.

Author Affiliations

By Kenji Maeda. Price, $5.50. Pp 156, with 70 tables and 34 figures. John Wiley & Sons, Inc., 605 Third Ave, New York 10016, 1965.

Arch Intern Med. 1966;117(6):844. doi:10.1001/archinte.1966.03870120108032

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


This book describes the author's studies on streptomyces products inhibiting mycobacteria presented in the 1963 Squibb Lectures on the Chemistry of Microbial Products. The lectures are presented annually in the fall at the Institute of Microbiology at Rutgers, the State University of New Jersey.

Of chief interest to the clinician is the large group of antibiotics which in vitro studies have shown to have some inhibitory effects on mycobacteria, 21 in the water soluble group and 25 in the water-insoluble group. Most of these are too toxic for human use. It is of interest that the water soluble basic antibiotics have the in vivo inhibitory effect that would be inferred from their in vitro action, while those that are not soluble in water have their inhibiting effect against tubercle bacilli only in vitro.

The author presents in detail the steps involved in purifying several antibiotics extracted from various streptomyces—pyridomycin, labilomycin,

First Page Preview View Large
First page PDF preview
First page PDF preview